首页> 外文期刊>Journal of Surgical Oncology >Clinical analysis of postoperative venous thromboembolism risk factors in lung cancer patients
【24h】

Clinical analysis of postoperative venous thromboembolism risk factors in lung cancer patients

机译:肺癌患者术后静脉血栓栓塞危险因素的临床分析

获取原文
获取原文并翻译 | 示例
           

摘要

Background and Objectives The objective of this study is to explore clinical risk factors for venous thromboembolism (VTE) in postoperative lung cancer patients in order to provide a basis for the prevention and treatment of postoperative VTE. Methods A total of 1,001 lung cancer patients were retrospectively analyzed. Each patient was confirmed with surgical pathology diagnosis and had a complete clinical and follow-up record. VTE was identified in a combination of spiral computed tomography (CT), pulmonary angiography, and color Doppler ultrasound. We used life table method to create an occurrence frequency curve of thrombosis. We also searched for high risk factors for postoperative VTE with Cox multivariate regression model and created frequency curves of thrombosis against different risk factors using Kaplan-Meier method. Results As of July 31, 2011, the median follow-up time is 25.73 ± 0.11 months (19.23-31.37). The cumulative frequency of VTE among 1,001 lung cancer patients is 2%, 3%, 4%, 5%, and 5.3% over 1, 3, 6, 12, and 30 months after the surgery. COX regression analysis showed that the hazard ratio of VTE occurrence in patients with incomplete resection relative to ones with complete resection is 9.867 (95% CI: 5.275-18.459, P = 0.000). And the hazard ratio of VTE occurrence is 3.472 (95% CI: 1.761-6.845, P = 0.000) in patients with anti-angiogenesis treatment compared to patients without such treatment. The hazard ratio of VTE occurrence is 2.808 (95% CI: 1.439-5.479, P = 0.002) in patients with EGFR-TKI treatment relative to patients without the treatment, and 7.520 (95% CI: 3.968-14.250, P = 0.000) in patients with an increase in D-dimer level relative to normal ones Conclusions The highest incidence of VTE is within 1 month after lung cancer surgery. High risk factors for VTE include incomplete surgical resection, postoperative use of anti-angiogenesis drugs, EGFR-TKI application and an increase in preoperative D-dimer level.
机译:背景与目的本研究的目的是探讨术后肺癌患者静脉血栓栓塞症(VTE)的临床危险因素,以便为预防和治疗术后VTE提供基础。方法对1001例肺癌患者进行回顾性分析。每位患者均经手术病理诊断确诊,并具有完整的临床和随访记录。在螺旋计算机断层扫描(CT),肺血管造影和彩色多普勒超声检查的结合中鉴定出VTE。我们使用生命表法创建血栓形成的发生频率曲线。我们还使用Cox多元回归模型搜索了术后VTE的高风险因素,并使用Kaplan-Meier方法针对不同风险因素创建了血栓形成频率曲线。结果截至2011年7月31日,中位随访时间为25.73±0.11个月(19.23-31.37)。术后1,3、6、12和30个月,在1,001名肺癌患者中,VTE的累积频率分别为2%,3%,4%,5%和5.3%。 COX回归分析显示,不完全切除患者相对完全切除患者发生VTE的危险比为9.867(95%CI:5.275-18.459,P = 0.000)。与未进行抗血管生成治疗的患者相比,发生抗血管生成治疗的患者发生VTE的风险比为3.472(95%CI:1.761-6.845,P = 0.000)。相对于未接受EGFR-TKI治疗的患者,发生VTE的风险比为2.808(95%CI:1.439-5.479,P = 0.002)和7.520(95%CI:3.968-14.250,P = 0.000)结论D-二聚体水平相对于正常水平升高的患者中VTE的最高发生率是在肺癌手术后1个月内。 VTE的高风险因素包括手术切除不完全,术后使用抗血管生成药物,应用EGFR-TKI以及术前D-二聚体水平升高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号